Le Lézard
Classified in: Ebola virus, Health, Covid-19 virus
Subject: MRR

Emerging Infectious Disease Global Market Trends 2022: Controlling Mosquitos Key for Disease Prevention


DUBLIN, Oct. 14, 2022 /PRNewswire/ -- The "Emerging Infectious Disease Market Trends, 2022" report has been added to  ResearchAndMarkets.com's offering.

Research and Markets Logo


The search for the next large-scale emerging disease was on before the COVID-19 pandemic. Respiratory diseases were among those suggested by Kalorama Information and other outlets and medical associations as possibilities for the next threat. The search is constant and is by no means limited to respiratory epidemics.

As the recent monkeypox concern has demonstrated, little-known pathogens can emerge and become large health threats. This necessitates the development of tests at laboratories. For business planners, it's worthwhile to have a resource describing the possible next pathogens of serious concern.

Emerging Infectious Disease Market Trends, 2022 is designed to provide a substantial look at Emerging Infectious Disease Trends with market numbers for significant categories.

This report includes:

Why is it important to examine the world of emerging infectious diseases? In a 2015 TED Talk, Microsoft creator Bill Gates warned that there was a lack of preparation for a viral epidemic. He predicted that it would be "microbes, not missiles" that would cause significant harm to humans. Now with a global focus on testing, Kalorama's update on all of the other diseases that could spread widely seems relevant. It's not to say that every disease will be like the COVID-19 pandemic - not all will be respiratory threats that can spread quickly. Some pathogens spread through contact or insect vectors, slower but often steadier pattern. Vector-based tests such as Zika and malaria remain worrying and new diseases through that transmission method are troubling. And non-respiratory diseases such as Ebola can still spread quickly from person to person if not tested for and treated quickly.

Fortunately, the IVD industry is ready and companies have the capacity to identify antigen targets and viral or bacterial RNA to be able to build high-sensitivity diagnostic products and produce tests at an ever-increasing rate. This report covers their efforts with existing emerging diseases.

Key Topics Covered:

Chapter 1: Executive Summary

Chapter 2: Discussion: The State of Emerging Infectious Diseases

Chapter 3: Viruses

Chapter 4: Bacterial Infections

Chapter 6: Tick-Borne Disease

Chapter 7: Other Emerging Infectious Diseases

Chapter 8: Markets for Major Emerging Infectious Diseases

Chapter 9: Products on the Market

For more information about this report visit https://www.researchandmarkets.com/r/3w697g

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets


These press releases may also interest you

18 mai 2024
Emmy-winning actor and St. Louis native Jon Hamm took the stage Saturday, May 18, to offer words of wisdom to the newest graduates of Saint Louis University (SLU) during the University's spring commencement in St. Louis. ...

18 mai 2024
Nearly 900 undergraduates of the Class of 2024 celebrated their send-off from Bentley University in a very different way than their 2020 arrival amid the COVID-19 pandemic. The 105th undergraduate commencement ceremony was marked by maskless smiles,...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

17 mai 2024
Federal, provincial and territorial (FPT) ministers responsible for culture and heritage held their annual meeting in Whitehorse, Yukon, on May 15?17, 2024, to discuss priority topics, share information and exchange best practices on current issues...

17 mai 2024
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class Period") of the important June 11, 2024 lead...



News published on and distributed by: